Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

8.9%

7 terminated/withdrawn out of 79 trials

Success Rate

84.4%

-2.1% vs industry average

Late-Stage Pipeline

29%

23 trials in Phase 3/4

Results Transparency

11%

4 of 38 completed trials have results

Key Signals

7 recruiting4 with results

Enrollment Performance

Analytics

N/A

18(28.6%)

Phase 4

14(22.2%)

Phase 2

12(19.0%)

Phase 1

10(15.9%)

Phase 3

9(14.3%)

63Total

N/A(18)

Phase 4(14)

Phase 2(12)

Phase 1(10)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (79)

Showing 20 of 79 trials

NCT07640308Phase 1Not Yet Recruiting

Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster

Role: collaborator

NCT05597735Phase 3Active Not Recruiting

Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease

Role: collaborator

NCT07584122Not ApplicableRecruiting

Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro

Role: lead

NCT07500415Not ApplicableRecruiting

Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro

Role: lead

NCT07497594Not ApplicableRecruiting

ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention

Role: lead

NCT07363031Phase 2Enrolling By Invitation

Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy

Role: collaborator

NCT06056037Not ApplicableRecruiting

Making ART Work Among Brazilian Youth

Role: collaborator

NCT07134725Phase 1Completed

Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

Role: collaborator

NCT03775460Not ApplicableActive Not Recruiting

Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum

Role: collaborator

NCT07062042Not ApplicableRecruiting

Empowering Narratives

Role: collaborator

NCT05507671Phase 3Active Not Recruiting

The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines

Role: lead

NCT05540470Not ApplicableCompleted

Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese Shield

Role: collaborator

NCT04672590Completed

COVID-19 Neurological Disease: A Prospective Study

Role: collaborator

NCT03128775Not ApplicableWithdrawn

Nudging Students Towards Healthy Diet and Physical Activity to Prevent Obesity

Role: collaborator

NCT04190303Completed

BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally

Role: collaborator

NCT03529396Phase 2Completed

Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients

Role: collaborator

NCT06306300Phase 4Recruiting

Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil)

Role: lead

NCT05343871Phase 4Completed

Immunogenicity and Safety of Fractional Booster Dose of COVID-19 Vaccines Available for Use in Pakistan/Brazil: A Phase 4 Dose-optimizing Trial

Role: collaborator

NCT06203925Unknown

Hepatitis C Virus Self-testing (HCVST) in Sexual and Gender Minorities in Rio de Janeiro

Role: lead

NCT05541952Phase 4Withdrawn

BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population

Role: collaborator